What Replimune Group, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 17 |
| Total trades | 6 | 31 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 819,409 |
| Disposed | 129,124 | 328,252 |
| Net activity | −129,124 | +491,157 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Astley-Sparke Philip | Director | Aug 20 | Gift · G | −50,000 | — | — | 1,362,414 |
| Hill Emily Luisa | Chief Financial Officer | Aug 17 | Sale for tax withholding · S | −9,256 | $14.28 | −$132K | 215,852 |
| Schwendenman Andrew | Chief Accounting Officer | Aug 10 | Sale for tax withholding · S | −7,632 | $12.97 | −$99K | 99,425 |
| Xynos Konstantinos | Chief Medical Officer | Aug 10 | Sale for tax withholding · S | −11,447 | $12.97 | −$148K | 224,215 |
| Hill Emily Luisa | Chief Financial Officer | Aug 10 | Sale for tax withholding · S | −11,448 | $12.97 | −$148K | 225,108 |
| Patel Sushil | Chief Executive Officer | Aug 10 | Sale for tax withholding · S | −39,341 | $12.97 | −$510K | 708,151 |
| Sarchi Christopher | Chief Commercial Officer | Jun 01 | Disclosed 10b5-1 sale · S | −12,000 | $9.24 | −$111K | 180,962 |
| Hill Emily Luisa | Chief Financial Officer | May 18 | Sale for tax withholding · S | −7,812 | $5.08 | −$39.7K | 236,556 |
| Sarchi Christopher | Chief Commercial Officer | May 18 | Sale for tax withholding · S | −8,626 | $5.08 | −$43.8K | 192,962 |
| Patel Sushil | Chief Executive Officer | May 18 | Sale for tax withholding · S | −37,324 | $5.08 | −$190K | 747,492 |
| Astley-Sparke Philip | Director | May 18 | Sale for tax withholding · S | −17,657 | $5.08 | −$89.7K | 1,412,414 |
| Schwendenman Andrew | Chief Accounting Officer | May 18 | Sale for tax withholding · S | −7,894 | $5.08 | −$40.1K | 107,057 |
| Xynos Konstantinos | Chief Medical Officer | May 18 | Sale for tax withholding · S | −14,023 | $5.08 | −$71.2K | 235,662 |
| Sarchi Christopher | Chief Commercial Officer | Apr 02 | Open-market sale · S | −6,500 | $8.01 | −$52.1K | 151,588 |
| Hill Emily Luisa | Chief Financial Officer | Apr 01 | Grant / award · A | +50,000 | — | — | 244,368 |
| Patel Sushil | Chief Executive Officer | Apr 01 | Grant / award · A | +251,240 | — | — | 784,816 |
| Schwendenman Andrew | Chief Accounting Officer | Apr 01 | Grant / award · A | −36,667 | — | — | 114,951 |
| Xynos Konstantinos | Chief Medical Officer | Apr 01 | Grant / award · A | +50,000 | — | — | 249,685 |
| Astley-Sparke Philip | Director | Apr 01 | Grant / award · A | +50,000 | — | — | 1,430,071 |
| Sarchi Christopher | Chief Commercial Officer | Apr 01 | Grant / award · A | +50,000 | — | — | 201,588 |
Loading...
